Follow Us TR

News Details

Achieve Life Sciences Announces Results from Evaluation of Cytisinicline (cytisine) versus Chantix® (varenicline) in 5-HT3 Receptor Binding Assay Study

About Achieve Life Sciences, Inc.
  • NASDAQ: $ACHV
  • Notified: $11.96
  • 07:01 EDT

Price Chart